Citigroup
VNRX icon

Citigroup’s VolitionRx Ltd VNRX Stock Holding History

Citigroup’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-436
Closed -$1.76K – 6282
2026
Q1 		$1.76K Buy
+436
New +$2.08K ﹤0.01% 5439
2025
Q4 		– Sell
-17
Closed -$236 – 6507
2025
Q3 		$236 Buy
+17
New +$226 ﹤0.01% 5754
2025
Q1 		– Sell
-74
Closed -$889 – 6000
2024
Q4 		$889 Buy
+74
New +$993 ﹤0.01% 5603
2022
Q2 		– Sell
-17
Closed -$1K – 6695
2022
Q1 		$1K Buy
+17
New +$964 ﹤0.01% 6223
2021
Q3 		– Sell
-1
Closed – – 6326
2021
Q2 		$0 Sell
1
-123
-99% -$8.32K ﹤0.01% 6422
2021
Q1 		$9K Sell
124
-124
-50% -$10.6K ﹤0.01% 5715
2020
Q4 		$19K Buy
248
+182
+276% +$12.5K ﹤0.01% 6697
2020
Q3 		$4K Sell
66
-112
-63% -$7.62K ﹤0.01% 7155
2020
Q2 		$14K Buy
178
+15
+9% +$1.08K ﹤0.01% 6872
2020
Q1 		$10K Buy
+163
New +$13.6K ﹤0.01% 7053
2017
Q4 		– Sell
-75
Closed -$4K – 7664
2017
Q3 		$4K Buy
+75
New +$4.4K ﹤0.01% 6912
2015
Q2 		– Hold
0
– – – 7776
2015
Q1 		– Hold
0
– – – 7456

Other funds holding VNRX

LIM
Lagoda Investment Management New York $182M AUM 58.16% 1-Year Est. Return
LM
Luminus Management Houston, Texas $146M AUM 27.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Citigroup's VNRX Position: Q2 2026 in Review

Citigroup sold out of VolitionRx Ltd (VNRX) in Q2 2026, closing a stake of 436 shares — an estimated $1.76K sold.

Citigroup first reported a position in VNRX in Q3 2017 and held it in 11 quarters. The position peaked at $19K in Q4 2020. 25 funds tracked by Wall St. Rank hold VNRX as of Q2 2026.

  • Citigroup reported no remaining VolitionRx Ltd position as of Q2 2026 after selling out during the quarter.
  • Citigroup sold 436 VolitionRx Ltd shares in Q2 2026, an estimated $1.76K.
  • Citigroup first reported a position in VolitionRx Ltd in Q3 2017 and held it in 11 quarters.
  • Citigroup's VolitionRx Ltd position peaked at $19K in Q4 2020.
  • 25 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.